These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 28044213)

  • 1. Polymorphisms of MTHFR C677T and A1298C associated with survival in patients with colorectal cancer treated with 5-fluorouracil-based chemotherapy.
    Yeh CC; Lai CY; Chang SN; Hsieh LL; Tang R; Sung FC; Lin YK
    Int J Clin Oncol; 2017 Jun; 22(3):484-493. PubMed ID: 28044213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and fluorouracil-based treatment in Taiwan colorectal cancer.
    Wu NC; Su SM; Lin TJ; Chin J; Hou CF; Yang JY; Liu WS; Chang LC
    Anticancer Drugs; 2015 Sep; 26(8):888-93. PubMed ID: 26111049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of polymorphisms MTHFR C677T and A1298C with risk of colorectal cancer, genetic and epigenetic characteristic of tumors, and response to chemotherapy.
    Fernández-Peralta AM; Daimiel L; Nejda N; Iglesias D; Medina Arana V; González-Aguilera JJ
    Int J Colorectal Dis; 2010 Feb; 25(2):141-51. PubMed ID: 19669769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between MTHFR polymorphisms and overall survival of colorectal cancer patients in Northeast China.
    Zhu L; Wang F; Hu F; Wang Y; Li D; Dong X; Cui B; Zhao Y
    Med Oncol; 2013 Mar; 30(1):467. PubMed ID: 23392576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylenetetrahydrofolate reductase polymorphisms and colorectal cancer prognosis: A meta-analysis.
    Chen XL; Wang YM; Zhao F; Chen Z; Yang X; Sun C; Gao Y; Yang TG; Tian G; Chen YM; Zhu SL; Lin XB; Liu FB
    J Gene Med; 2019 Sep; 21(9):e3114. PubMed ID: 31330573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients.
    Etienne-Grimaldi MC; Milano G; Maindrault-Goebel F; Chibaudel B; Formento JL; Francoual M; Lledo G; André T; Mabro M; Mineur L; Flesch M; Carola E; de Gramont A
    Br J Clin Pharmacol; 2010 Jan; 69(1):58-66. PubMed ID: 20078613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of folate metabolism-related genes and survival of patients with colorectal cancer in the Korean population.
    Jang MJ; Kim JW; Jeon YJ; Chong SY; Hong SP; Hwang SG; Oh D; Cho YK; Ji YG; Kim NK
    Gene; 2014 Jan; 533(2):558-64. PubMed ID: 24100087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allele and genotype frequencies of the polymorphic methylenetetrahydrofolate reductase and colorectal cancer among Jordanian population.
    Yousef AM; Shomaf M; Berger S; Ababneh N; Bobali Y; Ali D; Al-Hasan S; Diab O; Ismail S
    Asian Pac J Cancer Prev; 2013; 14(8):4559-65. PubMed ID: 24083702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C677T and A1298C MTHFR gene polymorphisms and response to fluoropyrimidine-based chemotherapy in Mestizo patients with metastatic colorectal cancer.
    Ramos-Esquivel A; Chinchilla-Monge R; Abbas J; Valle M
    Pharmacogenet Genomics; 2021 Dec; 31(9):191-199. PubMed ID: 34116533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of polymorphisms in folate-metabolizing genes with response to adjuvant chemotherapy of colorectal cancer.
    Yousef AM; Zawiah M; Al-Yacoub S; Kadi T; Tantawi DA; Al-Ramadhani H
    Cancer Chemother Pharmacol; 2018 Aug; 82(2):237-243. PubMed ID: 29845393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer.
    Zhang W; Press OA; Haiman CA; Yang DY; Gordon MA; Fazzone W; El-Khoueiry A; Iqbal S; Sherrod AE; Lurje G; Lenz HJ
    J Clin Oncol; 2007 Aug; 25(24):3726-31. PubMed ID: 17704422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation.
    Terrazzino S; Agostini M; Pucciarelli S; Pasetto LM; Friso ML; Ambrosi A; Lisi V; Leon A; Lise M; Nitti D
    Pharmacogenet Genomics; 2006 Nov; 16(11):817-24. PubMed ID: 17047490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polymorphism of methylenetetrahydrofolate reductase and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy].
    Gao CM; Lu JW; Toshiro T; Wu JZ; Cao HX; Chen HQ; Feng JF; Kazuo T
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1054-8. PubMed ID: 15769364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MTHFR Glu429Ala and ERCC5 His46His polymorphisms are associated with prognosis in colorectal cancer patients: analysis of two independent cohorts from Newfoundland.
    Negandhi AA; Hyde A; Dicks E; Pollett W; Younghusband BH; Parfrey P; Green RC; Savas S
    PLoS One; 2013; 8(4):e61469. PubMed ID: 23626689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Thymidylate Synthase and Methylenetetrahydrofolate Reductase Genotypes on Sensitivity to 5-Fluorouracil Treatment in Colorectal Cancer Cells.
    Naghibalhossaini F; Shefaghat M; Mansouri A; Jaberi H; Tatar M; Eftekhar E
    Acta Med Iran; 2017 Dec; 55(12):751-758. PubMed ID: 29373881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapy.
    Stanojevic A; Spasic J; Marinkovic M; Stojanovic-Rundic S; Jankovic R; Djuric A; Zoidakis J; Fijneman RJA; Castellvi-Bel S; Cavic M
    Front Genet; 2023; 14():1299599. PubMed ID: 38288161
    [No Abstract]   [Full Text] [Related]  

  • 17. Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer.
    Jiang Q; Chen K; Ma X; Li Q; Yu W; Shu G; Yao K
    Cancer Detect Prev; 2005; 29(2):146-54. PubMed ID: 15829374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of
    Lin KM; Yang MD; Tsai CW; Chang WS; Hsiao CL; Jeng LB; Yueh TC; Lee MC; Bau DT
    Anticancer Res; 2018 Apr; 38(4):2001-2006. PubMed ID: 29599316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients.
    Blank S; Rachakonda S; Keller G; Weichert W; Lordick F; Langer R; Springfeld C; Bruckner T; Becker K; Kumar R; Ott K
    BMC Cancer; 2014 Feb; 14():58. PubMed ID: 24490800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined genotype and haplotype distributions of MTHFR C677T and A1298C polymorphisms: A cross-sectional descriptive study of 13,473 Chinese adult women.
    Fan S; Yang B; Zhi X; Wang Y; Zheng Q; Sun G
    Medicine (Baltimore); 2016 Nov; 95(48):e5355. PubMed ID: 27902594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.